User:Mr. Ibrahem/Baloxavir marboxil

Baloxavir marboxil (BXM), sold under the brand name Xofluza, is an antiviral used to treat and prevent influenza (flu). It is used in those over the age of 11 who have been sick for less than 48 hours. It decreases recover time by about a day. It is taken by mouth as a single dose.

Common side effects include diarrhea, bronchitis, nausea, sinusitis, and headache. Other side effects may include anaphylaxis. Safety in pregnancy is unclear. It is a influenza virus polymerase acidic (PA) endonuclease inhibitor.

Baloxavir marboxil was approved for medical use in the United States and Japan in 2018. It was approved in Europe and the United Kingdom in 2021. In the United States a course of treatment costs about 160 USD as of 2022.